AU2002360424A1 - Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells - Google Patents

Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells Download PDF

Info

Publication number
AU2002360424A1
AU2002360424A1 AU2002360424A AU2002360424A AU2002360424A1 AU 2002360424 A1 AU2002360424 A1 AU 2002360424A1 AU 2002360424 A AU2002360424 A AU 2002360424A AU 2002360424 A AU2002360424 A AU 2002360424A AU 2002360424 A1 AU2002360424 A1 AU 2002360424A1
Authority
AU
Australia
Prior art keywords
cells
cell
human
oocytes
embryos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360424A
Other languages
English (en)
Inventor
Keith Campbell
Jose Cibelli
Michael West
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Institute for Regenerative Medicine
Original Assignee
Advanced Cell Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Cell Technology Inc filed Critical Advanced Cell Technology Inc
Publication of AU2002360424A1 publication Critical patent/AU2002360424A1/en
Priority to AU2008243183A priority Critical patent/AU2008243183A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8776—Primate embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AU2002360424A 2001-11-26 2002-11-26 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells Abandoned AU2002360424A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008243183A AU2008243183A1 (en) 2001-11-26 2008-11-07 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33251001P 2001-11-26 2001-11-26
US60/332,510 2001-11-26
PCT/US2002/037899 WO2003046141A2 (fr) 2001-11-26 2002-11-26 Procedes de production et d'utilisation de noyaux de cellules somatiques humaines reprogrammees et de cellules souches humaines autologues et isogeniques

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008243183A Division AU2008243183A1 (en) 2001-11-26 2008-11-07 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells

Publications (1)

Publication Number Publication Date
AU2002360424A1 true AU2002360424A1 (en) 2003-06-10

Family

ID=23298540

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002360424A Abandoned AU2002360424A1 (en) 2001-11-26 2002-11-26 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
AU2008243183A Abandoned AU2008243183A1 (en) 2001-11-26 2008-11-07 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008243183A Abandoned AU2008243183A1 (en) 2001-11-26 2008-11-07 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells

Country Status (7)

Country Link
US (3) US20030232430A1 (fr)
EP (1) EP1456374A4 (fr)
JP (1) JP2005510232A (fr)
AU (2) AU2002360424A1 (fr)
CA (1) CA2468292A1 (fr)
MX (1) MXPA04005010A (fr)
WO (1) WO2003046141A2 (fr)

Families Citing this family (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149175A0 (en) * 1999-10-28 2002-11-10 Univ Massachusetts Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US20050239125A1 (en) * 2000-09-06 2005-10-27 Hodge Timothy A Methods for genotype screening
AU2002317039B2 (en) * 2001-07-24 2007-10-04 Es Cell International Pte Ltd Methods of inducing differentiation of stem cells
US20030134422A1 (en) * 2002-01-16 2003-07-17 Sayre Chauncey Bigelow Stem cell maturation for all tissue lines
US20050170506A1 (en) * 2002-01-16 2005-08-04 Primegen Biotech Llc Therapeutic reprogramming, hybrid stem cells and maturation
US20050090004A1 (en) * 2003-01-16 2005-04-28 Sayre Chauncey B. Stem cell maturation for all tissue lines
US20040091936A1 (en) 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
AU2003237257A1 (en) 2002-05-24 2003-12-12 Advanced Cell Technology, Inc. A bank of stem cells for transplantation
BRPI0414961A (pt) * 2003-10-03 2006-11-07 Keiichi Fukuda processo de indução da diferenciação de células tronco em células do miocárdio
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
CN103898047B (zh) * 2003-12-23 2020-03-03 维亚希特公司 定形内胚层
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
KR101398356B1 (ko) * 2004-01-23 2014-05-23 어드밴스드 셀 테크놀로지, 인코포레이티드 망막 변성 질환 치료를 위한 개선된 양식
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
EP1725654B1 (fr) * 2004-03-19 2019-05-01 Asterias Biotherapeutics, Inc. Procede destine a preparer des preparations cardiomyocytes haute purete utilisees dans la medecine regenerative
ES2701704T3 (es) 2004-04-07 2019-02-25 Ncardia Ag Sistemas de ensayo tisulares funcionales no invasivos in vitro
EP2377922B1 (fr) * 2004-04-27 2020-04-08 Viacyte, Inc. Endoderme exprimant PDX1
DK1740612T3 (da) * 2004-04-27 2019-10-07 Viacyte Inc Pdx1 udtrykkende endoderm
WO2005108598A1 (fr) 2004-05-11 2005-11-17 Axiogenesis Ag Dosage pour la decouverte de medicament reposant sur des cellules differenciees in vitro
GB2429718B (en) * 2004-06-01 2008-12-17 Es Cell Int Pte Ltd Improved cardiomyocyte differentiation
US20050272149A1 (en) * 2004-06-02 2005-12-08 Life & Brain Gmbh Therapeutic delivery of adenosine into a tissue
WO2005123902A1 (fr) * 2004-06-18 2005-12-29 Riken Méthode pour induire la différenciation de cellules souches embryonnaires en nerf à l'aide d'une culture en suspension exempte de sérum
JP5687816B2 (ja) * 2004-07-09 2015-03-25 ヴィアサイト，インコーポレイテッド 胚体内胚葉を分化させるための因子を同定する方法
EP3505622A1 (fr) * 2004-07-09 2019-07-03 Viacyte, Inc. Cellules mésendodermiques et cellules de ligne pré-primitive
US7442548B2 (en) * 2004-09-08 2008-10-28 Wisconsin Alumni Research Foundation Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid
WO2006055685A2 (fr) * 2004-11-17 2006-05-26 Neuralstem, Inc. Transplantation de cellules neurales humaines pour traiter des troubles neurodegeneratifs
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
AU2005322007B2 (en) * 2004-12-23 2011-06-30 Viacyte, Inc. Expansion of definitive endoderm cells
ES2525684T3 (es) * 2004-12-29 2014-12-29 Hadasit Medical Research Services And Development Ltd. Sistemas de cultivo de células madre
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US20090093403A1 (en) 2007-03-01 2009-04-09 Feng Zhang Systems, methods and compositions for optical stimulation of target cells
EP2465925A1 (fr) 2005-07-22 2012-06-20 The Board Of Trustees Of The Leland Canal à cations activés par la lumière et ses utilisations
US10052497B2 (en) 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
ES2933478T3 (es) 2005-08-03 2023-02-09 Astellas Inst For Regenerative Medicine Métodos mejorados de reprogramación de células somáticas animales
US7732202B2 (en) 2005-10-21 2010-06-08 International Stem Cell Corporation Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells
PL1957636T3 (pl) 2005-10-27 2018-12-31 Viacyte, Inc. Grzbietowa i brzuszna endoderma jelita przedniego wykazująca ekspresję pdx1
WO2007101130A2 (fr) * 2006-02-23 2007-09-07 Novocell, Inc. Compositions et procédés utiles pour la culture de cellules différenciables
EP2650360B1 (fr) * 2006-03-02 2019-07-24 Viacyte, Inc. Cellules précurseurs endocrines, cellules exprimant des hormones pancréatiques et procédés de production
CN101454441B (zh) * 2006-03-06 2013-06-26 新加坡科技研究局 人胚胎干细胞方法与podxl表达
GEP20135796B (en) * 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US20070280907A1 (en) * 2006-04-07 2007-12-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells
SE0850071L (sv) * 2006-04-10 2008-12-19 Wisconsin Alumni Res Found Reagenser och förfaranden för användning av humana embryonala stamceller för att utvärdera toxicitet av farmaceutiska föreningar och andra kemikalier.
KR102651433B1 (ko) 2006-04-14 2024-03-25 아스텔라스 인스티튜트 포 리제너러티브 메디슨 혈관 콜로니 형성 세포
US8293529B2 (en) * 2006-04-28 2012-10-23 Daiichi Sankyo Company, Limited Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
EP2021462B1 (fr) * 2006-04-28 2019-01-09 Lifescan, Inc. Différentiation de cellules souches embryonnaires humaines
AU2007248412A1 (en) * 2006-05-03 2007-11-15 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
WO2008006605A2 (fr) * 2006-07-13 2008-01-17 Cellartis Ab Nouvelle population de cellules précurseurs cardiaques multipotentes dérivées de cellules souches dérivées de blastocystes humains
JP2009544313A (ja) * 2006-07-24 2009-12-17 インターナショナル ステム セル コーポレイション 網膜幹細胞由来の合成角膜
WO2008026198A2 (fr) 2006-08-28 2008-03-06 Yeda Research And Development Co. Ltd. Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
JP2008099662A (ja) 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
WO2008041909A1 (fr) * 2006-10-02 2008-04-10 Norrfors Searl Procédé de fabrication de composants natifs, tels que facteurs de croissance ou protéines de matrice extracellulaire, par mise en culture de cellules d'échantillons de tissu pour la réparation tissulaire
GB0622394D0 (en) * 2006-11-09 2006-12-20 Univ Cambridge Tech Differentiation of pluripotent cells
EP2457997B1 (fr) * 2007-01-03 2016-08-31 NeoStem Oncology, LLC Support de croissance de cellules souches et procédés de fabrication et d'utilisation associés
WO2008084401A2 (fr) * 2007-01-04 2008-07-17 Karl Tryggvason Composition et procédé pour permettre la prolifération de cellules souches pluripotentes
WO2008086470A1 (fr) 2007-01-10 2008-07-17 The Board Of Trustees Of The Leland Stanford Junior University Système pour stimulation optique de cellules cibles
WO2008101128A1 (fr) 2007-02-14 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Système, procédé et applications comprenant l'identification de circuits biologiques tels que des caractéristiques neurologiques
WO2008103462A2 (fr) * 2007-02-23 2008-08-28 Advanced Cell Technology, Inc. Procédés hautement efficaces pour reprogrammer des cellules différenciées et pour produire des animaux et des cellules souches embryonnaires à partir de cellules reprogrammées
WO2009005844A1 (fr) * 2007-07-02 2009-01-08 Gregory Aharonian Procédés permettant une spermatogenèse de mammifère femelle et une oogenèse de mammifère mâle à l'aide d'une nanobiologie synthétique
US20100190202A1 (en) * 2007-07-20 2010-07-29 Cellartis Ab Novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells
IL292561A (en) 2007-10-12 2022-06-01 Astellas Inst For Regenerative Medicine Improved methods of rpe cell production and rpe cell preparations
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US20090170203A1 (en) * 2008-01-01 2009-07-02 Aharonian Gregory P Methods for female mammalian spermatogenesis and male mammalian oogenesis using synthetic nanobiology
EP2100954A1 (fr) * 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Procédé pour générer des cellules progénitrices cardiaques de primate pour un usage clinique à partir de cellules souches embryonnaires, et leurs applications
KR20110005280A (ko) 2008-04-23 2011-01-17 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 표적 세포의 광학적 자극을 위한 시스템, 방법 및 조성물
ES2685969T3 (es) 2008-05-06 2018-10-15 Astellas Institute For Regenerative Medicine Células formadoras de colonias hemangioblásticas y células hemangioblásticas no injertables
KR20210003301A (ko) 2008-05-06 2021-01-11 아스텔라스 인스티튜트 포 리제너러티브 메디슨 다능성 줄기세포로부터 유도된 탈핵 적혈구계 세포를 생산하는 방법
WO2009155369A1 (fr) 2008-06-17 2009-12-23 The Board Of Trustees Of The Leland Stanford Junior University Appareil et procédés pour commander le développement cellulaire
US9101759B2 (en) 2008-07-08 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
WO2010018652A1 (fr) * 2008-08-13 2010-02-18 Keio University Agent favorisant la différentiation neuronale et procédé associé
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
WO2011016423A1 (fr) * 2009-08-02 2011-02-10 学校法人 東京女子医科大学 Feuillet de cellules de langerhans, procédé de production associé, et application associée
KR20120102709A (ko) 2009-11-17 2012-09-18 어드밴스드 셀 테크놀로지, 인코포레이티드 인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제
US9988603B2 (en) 2009-12-04 2018-06-05 Stem Cell & Regenerative Medicine International Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions
WO2011091944A1 (fr) * 2010-01-26 2011-08-04 Université Libre de Bruxelles Outils pour isoler et suivre des cellules progénitrices cardiovasculaires
SG183899A1 (en) 2010-03-17 2012-10-30 Univ Leland Stanford Junior Light-sensitive ion-passing molecules
JP5777115B2 (ja) * 2010-03-18 2015-09-09 国立大学法人京都大学 多能性幹細胞から中胚葉細胞への分化誘導法
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
EP2596119B8 (fr) 2010-07-23 2021-06-02 Astellas Institute for Regenerative Medicine Procédés de détection de sous-populations rares de cellules et compositions de cellules très purifiées
EP2412724A1 (fr) * 2010-07-29 2012-02-01 Centre National de la Recherche Scientifique (C.N.R.S) Régulation de l'activité 4 glypican pour moduler le sort de cellules souches et leurs utilisations
CN103189502A (zh) 2010-08-27 2013-07-03 大学健康网络 基于sirpa表达富集源自多能干细胞的心肌祖细胞和心肌细胞的方法
EP3572501A1 (fr) 2010-09-07 2019-11-27 Technion Research & Development Foundation Limited Nouveaux procédés et milieux de culture destinés à la culture de cellules souches pluripotentes
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
EP2635108B1 (fr) 2010-11-05 2019-01-23 The Board of Trustees of the Leland Stanford Junior University Opsines chimériques activées par la lumière et leurs procédés d'utilisation
JP6328424B6 (ja) 2010-11-05 2018-07-11 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 記憶機能の制御および特性化
WO2012061690A2 (fr) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Dysfonctionnement du snc contrôlé optiquement
EP2635346B1 (fr) 2010-11-05 2017-03-29 The Board of Trustees of the Leland Stanford Junior University Régulation optogénétique de comportements associés au système de récompense
AU2011323199B2 (en) 2010-11-05 2016-01-28 The Board Of Trustees Of The Leland Stanford Junior University Stabilized step function opsin proteins and methods of using the same
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
AU2012340020A1 (en) 2011-11-14 2014-07-03 Astellas Institute For Regenerative Medicine Pharmaceutical preparations of human RPE cells and uses thereof
CN107936097A (zh) 2011-12-16 2018-04-20 斯坦福大学托管董事会 视蛋白多肽及其使用方法
WO2013106677A1 (fr) * 2012-01-13 2013-07-18 The General Hospital Corporation Cellules progénitrices de poumon humain isolé et leurs utilisations
GB201202319D0 (en) * 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
CN104363961B (zh) 2012-02-21 2017-10-03 斯坦福大学托管董事会 用于治疗盆底神经源性病症的组合物和方法
WO2013142237A1 (fr) * 2012-03-23 2013-09-26 Aastrom Biosciences, Inc. Compositions cellulaires et méthodes d'utilisation
US20140099292A1 (en) * 2012-03-23 2014-04-10 Aastrom Biosciences, Inc. CD14+ Cell Compositions and Methods of Using Same
JP6251734B2 (ja) * 2012-05-03 2017-12-27 フレッド ハッチンソン キャンサー リサーチ センター 親和性増強型ｔ細胞受容体およびその作製方法
US9587104B2 (en) 2012-06-07 2017-03-07 The University Of Queensland Release media
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
TWI719468B (zh) * 2012-07-24 2021-02-21 日商日產化學股份有限公司 培養基組成物、其用途、細胞或組織之培養方法及細胞或組織培養物
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
WO2014052458A1 (fr) * 2012-09-25 2014-04-03 Yale University Différentiation de cellules ips humaines en cellules alvéolaires humaines de type ii par l'intermédiaire d'un endoderme définitif
US10294457B2 (en) 2012-11-29 2019-05-21 Takara Bio Europe Ab Maturation of hepatocyte-like cells derived from human pluripotent stem cells
CA2896053A1 (fr) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Procedes de production de plaquettes a partir de cellules souches pluripotentes, et compositions associees
US20160073616A1 (en) 2013-01-29 2016-03-17 The University Of Tokyo Method for producing chimeric animal
KR20150122688A (ko) 2013-02-15 2015-11-02 의료법인 성광의료재단 체세포 핵 이식을 이용하는 단위생식 줄기세포 및 환자-특이적 인간 배아줄기세포의 제조
EP2968997B1 (fr) 2013-03-15 2019-06-26 The Board of Trustees of the Leland Stanford Junior University Contrôle optogénétique de l'état comportemental
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
CA3205855A1 (fr) 2013-04-16 2014-10-23 Orbsen Therapeutics Limited Utilisation medicale du syndecane-2
AU2014260101B2 (en) 2013-04-29 2018-07-26 Humboldt-Universitat Zu Berlin Devices, systems and methods for optogenetic modulation of action potentials in target cells
KR101588394B1 (ko) 2013-05-09 2016-01-25 라정찬 줄기세포의 재생능 향상을 위한 배지 조성물 및 이를 이용한 줄기세포의 배양방법
WO2014197421A1 (fr) 2013-06-05 2014-12-11 Biotime, Inc. Compositions et procédés pour la régénération de tissus induite chez des espèces mammaliennes
EP3011014A4 (fr) * 2013-06-14 2017-02-08 The University of Queensland Cellules progénitrices rénales
WO2015012415A1 (fr) * 2013-07-26 2015-01-29 宇部興産株式会社 Procédé de culture cellulaire, appareil et kit de culture cellulaire
WO2015022545A2 (fr) * 2013-08-14 2015-02-19 Reneuron Limited Microparticules de cellules souches et miarn
GB201317887D0 (en) * 2013-10-09 2013-11-20 Reneuron Ltd Product
AU2014306679A1 (en) 2013-08-14 2016-03-10 Circuit Therapeutics, Inc. Compositions and methods for controlling pain
EP2857501A1 (fr) * 2013-10-03 2015-04-08 ETH Zurich Reprogrammation de cellules souches pluripotentes pour le contrôle amélioré de leurs voies de différentiation
GB201317869D0 (en) * 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
EP3858378A1 (fr) * 2013-11-21 2021-08-04 Autolus Limited Cellule
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
JP6596708B2 (ja) * 2014-05-20 2019-10-30 国立大学法人東京工業大学 インスリン産生細胞の分化誘導方法
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
WO2016008937A1 (fr) * 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés de transfert intercellulaire de mitochondries isolées dans des cellules receveuses
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
JP6920207B2 (ja) 2015-03-20 2021-08-18 オルブセン セラピューティクス リミテッド シンデカン−２のモジュレーターとその使用
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US11535824B2 (en) 2015-10-29 2022-12-27 Sung Kwang Medical Foundation Nuclear transfer
EP3190176A1 (fr) 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Procédé de développement de culture tissulaire sur échafaudage et culture de tissus différenciés
EP3922253A1 (fr) 2016-01-15 2021-12-15 Orbsen Therapeutics Limited Compositions d'exosomes à base de sdc-2 et leurs procédés d'isolement et d'utilisation
EP3205718A1 (fr) 2016-02-15 2017-08-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Moyens et procédés pour la différenciation cellulaire
JPWO2017141900A1 (ja) * 2016-02-16 2019-01-24 学校法人慶應義塾 多能性幹細胞の神経幹細胞への分化用培地及びその使用
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CA3026318C (fr) 2016-06-01 2023-04-04 Miltenyi Biotec Gmbh Procede de production, d'identification et d'isolement de cardiomyocytes derives de cellules souches pluripotentes humaines et sous-populations de cardiomyocytes
AU2017274145B2 (en) 2016-06-02 2020-07-23 Sigma-Aldrich Co Llc Using programmable DNA binding proteins to enhance targeted genome modification
US20200308548A1 (en) * 2016-07-01 2020-10-01 Centre National De La Recherche Scientifique (Cnrs) Amplifying Beta Cell Differentiation with Small Molecules BET (Bromodomain And Extraterminal Family Of Bromodomain-Containing Proteins) Inhibitors
JP2019537729A (ja) 2016-09-28 2019-12-26 オルガノボ インコーポレイテッド アッセイにおける人工腎臓組織の使用
CN110573610A (zh) 2017-03-08 2019-12-13 大日本住友制药株式会社 视网膜色素上皮细胞的制备方法
WO2018172335A1 (fr) 2017-03-20 2018-09-27 Ifom Fondazione Istituto Firc Di Oncologia Molecolare Procédé de génération de cellules souches de type 2c
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US20210147807A1 (en) 2017-06-14 2021-05-20 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
CA3066790C (fr) 2017-07-11 2023-07-18 Sigma-Aldrich Co. Llc Utilisation de domaines de proteines interagissant avec des nucleosomes pour ameliorer la modification ciblee du genome
JP7174758B2 (ja) 2017-07-14 2022-11-17 オーブセン セラピューティクス リミテッド Ｃｄ３９間質幹細胞の単離方法と使用
US20200173983A1 (en) 2017-07-17 2020-06-04 Miltenyi Biotec B.V. & Co. KG A method for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells
KR102494449B1 (ko) 2018-02-15 2023-01-31 시그마-알드리치 컴퍼니., 엘엘씨 진핵 게놈 변형을 위한 조작된 cas9 시스템
MX2020011757A (es) 2018-05-10 2021-01-08 Auxolytic Ltd Metodos y composiciones de terapia genica que utilizan celulas regulables auxotroficas.
US20210308188A1 (en) 2018-08-24 2021-10-07 Sumitomo Chemical Company, Limited Cell cluster including olfactory neuron or precursor cell thereof, and method for producing same
US20220098536A1 (en) 2019-01-04 2022-03-31 Oribiotech Ltd Cell processing container, cell processing system and methods of use thereof
WO2020165059A1 (fr) 2019-02-11 2020-08-20 Miltenyi Biotec B.V. & Co. KG Génération de structures de tissu artificiel dérivées de cellules souches pluripotentes humaines sans matrices tridimensionnelles
WO2020168102A1 (fr) 2019-02-15 2020-08-20 Sigma-Aldrich Co. Llc Protéines et systèmes de fusion crispr/cas
EP3927812B1 (fr) 2019-02-19 2023-09-06 Miltenyi Biotec B.V. & Co. KG Milieu de culture cellulaire et procédé de génération d'organoïdes épithéliales à partir de cellules souches épithéliales
WO2020232132A1 (fr) 2019-05-13 2020-11-19 Emd Millipore Corporation Vecteurs d'arn à auto-réplication synthétiques codant pour des protéines crispr et leurs utilisations
US20220233602A1 (en) 2019-07-05 2022-07-28 Novo Nordisk A/S Generation of neural stem cell lines derived from human pluripotent stem cells
WO2021006075A1 (fr) 2019-07-05 2021-01-14 株式会社Ｊｉｋｓａｋ Ｂｉｏｅｎｇｉｎｅｅｒｉｎｇ Procédé induisant la formation de synapses neuronales et microbilles utilisées dans ledit procédé
EP3792346B1 (fr) 2019-09-13 2023-07-26 Miltenyi Biotec B.V. & Co. KG Procédé de production d'une composition cellulaire de cellules progénitrices dopaminergiques du mésencéphale ventral
US20220389378A1 (en) 2019-11-22 2022-12-08 Novo Nordisk A/S Spin-aggregated neural microspheres and the application thereof
JP2023514327A (ja) 2020-03-11 2023-04-05 シグマ－アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー ゲノム改変のための高忠実度ＳｐＣａｓ９ヌクレアーゼ
AR124419A1 (es) 2020-12-18 2023-03-29 Novo Nordisk As Células seguras invisibles para el sistema inmunitario
WO2022136215A1 (fr) 2020-12-21 2022-06-30 Novo Nordisk A/S Cellules immuno-furtives sûres
CN117642493A (zh) 2021-07-13 2024-03-01 诺和诺德股份有限公司 人类多能干细胞及其衍生产物的大规模建库方法
CN117616276A (zh) 2021-07-14 2024-02-27 诺和诺德股份有限公司 提供富含神经元及其前体的细胞群体的方法
WO2023077149A1 (fr) 2021-11-01 2023-05-04 Sigma-Aldrich Co. Llc Amplificateurs d'électroporation pour systèmes crispr-cas
WO2023110824A1 (fr) 2021-12-15 2023-06-22 Novo Nordisk A/S Nouvelle protéine associée à l'intégrine (iap)
WO2023118101A1 (fr) 2021-12-21 2023-06-29 Novo Nordisk A/S Inhibition superposée de bmp pour l'induction neuronale des cellules souches pluripotentes
WO2023144404A1 (fr) 2022-01-31 2023-08-03 Novo Nordisk A/S Nouvelle protéine associée aux intégrines (iap)
WO2024003349A1 (fr) 2022-07-01 2024-01-04 Novo Nordisk A/S Amélioration de la différenciation neuronale de cellules progénitrices neurales du mésencéphale ventral
WO2024008810A1 (fr) 2022-07-06 2024-01-11 Novo Nordisk A/S Différenciation de cellules souches en cellules endocrines pancréatiques
FR3138149A1 (fr) 2022-07-25 2024-01-26 Pierre Fabre Dermo-Cosmetique Méthode d’évaluation in vitro de l’activité photoprotectrice d’un actif
WO2024008979A1 (fr) 2022-09-30 2024-01-11 Novo Nordisk A/S Protéine chimérique se liant à sirp-alpha

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
BR9711204A (pt) * 1996-08-19 1999-08-17 Univ Massachusetts Linhagens de c-lulas embriÄnicas ou similares s indiferenciadas produzidas por transplante nuclear de esp-cies hibridas
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6011197A (en) * 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
US20020019993A1 (en) * 1998-01-21 2002-02-14 Teruhiko Wakayama Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei
WO2001030970A2 (fr) * 1999-10-27 2001-05-03 Advanced Cell Technology, Inc. Protocole ameliore d'activation d'oocytes
US20030129745A1 (en) * 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
IL149175A0 (en) * 1999-10-28 2002-11-10 Univ Massachusetts Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
EP1241935A2 (fr) * 1999-12-17 2002-09-25 Gerald Schatten Procedes de production d'animaux transgeniques
US20040091936A1 (en) * 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank

Also Published As

Publication number Publication date
US20090137040A1 (en) 2009-05-28
US20030232430A1 (en) 2003-12-18
WO2003046141A3 (fr) 2003-12-04
MXPA04005010A (es) 2005-04-08
US20130102073A1 (en) 2013-04-25
WO2003046141A2 (fr) 2003-06-05
EP1456374A4 (fr) 2005-08-17
CA2468292A1 (fr) 2003-06-05
AU2008243183A1 (en) 2008-12-04
EP1456374A2 (fr) 2004-09-15
JP2005510232A (ja) 2005-04-21

Similar Documents

Publication Publication Date Title
US20030232430A1 (en) Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
Cibelli et al. Rapid communication: somatic cell nuclear transfer in humans: pronuclear and early embryonic development
US20200181567A1 (en) Methods of reprogramming animal somatic cells
AU742363B2 (en) Nuclear transfer with differentiated fetal and adult donor cells
CA2387506C (fr) Production gynogenetique ou androgenetique de cellules et de lignees cellulaires pluripotentes et leur utilisation dans la production de cellules et de tissus differencies
CA2317494A1 (fr) Clonage faisant appel a des noyaux donnes de cellules foetales et adultes differenciees
EP0739412A1 (fr) Cellules souches d'embryons utilisees comme donneuses de noyaux et procedes de transfert de noyaux pour la production d'animaux chimeriques et transgeniques
CA2294916A1 (fr) Clonage a l'aide de noyaux donneurs a partir de cellules differentiees ne presentant pas de carence serique
US20080044392A1 (en) Isolation of Stem Cell-Like Cells and Use Thereof
EP1198169B1 (fr) Processus de reprogrammation cellulaire par production d'un heterocaryon
AU2010238747A1 (en) Methods for mitochondrial DNA replacement in oocytes
US7527974B2 (en) Embryonic stem cells derived from human somatic cell—rabbit oocyte NT units
Hwang et al. Cloned human embryonic stem cells for tissue repair and transplantation
AU771102B2 (en) Cell reprogramming
WO2008134522A1 (fr) Dérivation de cellules souches embryonnaires
AU2011202964A1 (en) Nuclear transfer with differentiated fetal and adult donor cells

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted